PATENT CLAIM ANALYSIS

Application Number: 15991323
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "567000"]

Abstract:
Cyclopentene carboxylic acid-related compounds as GABA-AT inhibitors for treatment of various addictions, disorders and disease states.

Claim (Index 13):
The method of  claim 11  wherein said psychological disorder selected from general anxiety disorder, pathological or compulsive gambling disorder, compulsive eating, body dysmorphic disorder, hypochondriasis, pathologic grooming conditions, kleptomania, pyromania, attention deficit hyperactivity disorder and impulse control disorders and combinations thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15289480', '15586730', '13581187', '15712793', '15065487']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.76941099974211
- 35 USC 102 Novelty (BERT): 0.5668385071163594
- Combined Prediction Score: 0.749153750479535
- Mean Citation Score: 336.6300520000001
- Max Citation Score: 448.89084
- Similarity Product: 336.6656416939473

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test